Ultragenyx Pharmaceuticals initiates Phase 2 study of UX007
moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]
RARE
Ultragenyx Announces Initiation of Phase 2 Study for Patients with Long-Chain Fatty Acid Oxidation Disorders
[GlobeNewswire] – NOVATO, Calif. — Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that the first patient has … moreView todays social media effects on RAREView the latest stocks trending across Twitter. Click to view dashboardSee who Ultragenyx is hiring next, click here to view […]
